OpenAI Introduces Specialized Artificial Intelligence Model Designed Specifically for Biomedical Research and Drug Discovery
Silicon Valley technology firm OpenAI has unveiled a highly advanced Artificial Intelligence system trained exclusively on medical literature and biological data, partnering with major United States pharmaceutical companies to dramatically accelerate the discovery and testing of life-saving medical treatments.